News
New paper in British Journal of Cancer
Our new paper "Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival" has been published in British Journal of Cancer.
Photo:
Martha C Enger et al
Main content
Updated: 06.03.2020 (First published: 15.08.2019)
Click the link to read the paper